Concepedia

Publication | Open Access

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

DOIFull Paper Access

330

Citations

29

References

2014

Year

Jan A. Burger, Michael J. Keating, William G. Wierda, Elena Hartmann, Julia Hoellenriegel, Nathalie Y. Rosin, Iris de Weerdt, Ghayathri Jeyakumar, Alessandra Ferrajoli, Marylou Cárdenas-Turanzas,
The Lancet Oncology

References

YearCitations

Page 1